• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/13

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

13 Cards in this Set

  • Front
  • Back

List classes of oral hypoglycaemic agents

Gliptins


Biguanidines


Sulphonylureas


Thiazolidinedones


Acarbose


Meglitinides

Biguanidines


- MOA

Eg Metformin




Increases insulin sensitivity and promotes genetic expression:


Decreases glucose gut uptake


Increases skeletal muscle uptake


Decreases GNG in liver


Increases fatty oxidation and reduces TG/plasma cholesterol





Biguanidines


- SE

GI disturbance - usually transient


Can decrease appetite




Rare but serious


Lactic acidosis - more common in renal failure, dehyrdated

Sulphonylureas


- MOA

Depolarise insulin beta cells via K-ATPase pump inhibition --> Ca++ influx --> insulin release




May decrease peripheral insulin resistance over time




Requires functioning pancreas

Sulphonylureas


- SEs

GI disturbance


Wt gain


Hypoglycaemia


Accumulation in renal failure




Rarer:


Hepatic derangement


Blood dyscrasias



Acarbose


- MOA

Blocks degradation of polysaccharides in gut --> reduced absorption --> prevents post prandial rise

Acarbose


- SE

GI disturbance - increased sucrose reaching gut flora




Hepatic enzyme derangement

Thiazolidinedones


eg - Pioglitazone




MOA

Activates gene transcription via nuclear receptor to increase insulin sensitivity


- mainly pro insulin effects


- takes 1-2 months to have effect

Thiazolidinedones


- SEs



Fluid retention

- Na absorption in collecting duct


Wt gain


Rosiglitazone - removed due to increased rates of MI



Gliptins


- Sitagliptin

Decreases rate of breakdown of incretins - by blocking DPP4 action.


(substances released by GI in response to glucose in diet which stimulate insulin release)

Gliptins


- SEs

No weight gain


GI disturbance




rarely


Hepatic dysfn


Pancreatitis


Exacerbation of CCF

Meglitinides:


- Repaglinide


- MOA

increases insulin release by inhibting K-ATPase function



Meglitinides


- Side effects

Causes hypoglycaemias


reduced risk as causes